Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

287 results
Display

Validity of Diagnostic Codes for Identification of Psoriasis Patients in Korea

Ham SP, Oh JH, Park HJ, Kim JU, Kim HY, Jung SY, Choi SY, Seol JE, Kim H, Kim MS, Lee UH, Choi M, Park HJ

BACKGROUND: Recently, the number of nationwide medical researches on psoriasis using the National Health Insurance Service database has been on the rise. However, identification of psoriasis using diagnostic codes alone...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Characteristics of Pruritus according to Morphological Phenotype of Psoriasis and Association with Neuropeptides and Interleukin-31

Park SM, Kim GW, Kim HS, Ko HC, Kim MB, Kim BS

BACKGROUND: Pruritus is a common symptom in psoriasis. However, few studies have assessed the characteristics of pruritus according to morphological phenotypes of psoriasis. OBJECTIVE: To investigate the characteristics of pruritus according...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Widespread Dermatophytosis during Interleukin-17A Inhibitor Treatment in Psoriasis Patient with Tinea Unguium

Lee J, Na N, Park J

Interleukin-17 (IL-17) is secreted by a class of helper T cells called Th17 cells, which stimulates keratinocytes to secrete proinflammatory mediator and to recruit other inflammatory cells in psoriatic skins....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Linear Psoriasis along Blashko's Line

Kim S, Ko J, Hong D

  • KMID: 2470223
  • Korean J Dermatol.
  • 2019 Dec;57(10):640-642.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of Systemic Psoriasis Therapies on the C-Reactive Protein and the Neutrophil-Lymphocyte Ratio

Aktaş Karabay E, Aksu Çerman A, Demir D, Kıvanç Altunay I

BACKGROUND: Currently, no generally accepted laboratory marker for monitorizing the disease activity and therapy response of psoriasis is known. OBJECTIVE: The aim of the study is to evaluate the effects of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Exfoliative Dermatitis Induced by Phototherapy Secondary to Pustular Psoriasis

Park SJ, Jeong GJ, Hong JK, Seo SJ

  • KMID: 2465923
  • Korean J Dermatol.
  • 2019 Nov;57(9):556-557.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparative Study of Quality of Life in Patients with Scalp Psoriasis Treated Using Topical Steroid Alone vs. Topical Steroid Combined with Cyclosporine

Kim M, Yang S, Kim BR, Youn SW

  • KMID: 2465915
  • Korean J Dermatol.
  • 2019 Nov;57(9):513-518.
BACKGROUND: Scalp psoriasis severely affects patients' quality of life, and patients may occasionally be refractory to topical steroid application. Although systemic therapy combined with topical steroid application is recommended for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is It Possible to Discontinue Tumor Necrosis Factor Antagonists after Psoriasis Remission?

Kim B, Maverakis , Raychaudhuri SP

Tumor necrosis factor (TNF) antagonists are highly effective treatments for psoriasis. These agents provide the opportunity to improve disease activity and achieve clinical remission. Despite its efficacy, long-term use of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment Outcomes and Response Pattern of Ustekinumab in Korean Patients with Psoriasis: A Retrospective Single-center Study

Oh J, Kim T, Lee MG

  • KMID: 2465951
  • Korean J Dermatol.
  • 2019 Sep;57(8):441-447.
BACKGROUND: Psoriasis is a chronic immune-mediated inflammatory skin disease affecting 2~3% of the worldwide population. Ustekinumab, an IL-12/23p40 inhibitor, is a biologic reported to be effective and safe in treating...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparative Study of Clinical Characteristics according to Therapeutic Efficacy and Drug Survival of Cyclosporine or Methotrexate in Psoriasis Vulgaris

Lee HS, Kwon SH, Lee ES

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association between Homocysteine Levels and Psoriasis: A Meta-Analysis

Kim JE, Lee HJ, Lee JS, Whang KU, Park YL, Lee SY, Kim HJ

BACKGROUND: Psoriasis is a multifactorial disease associated with an increased risk for metabolic syndrome and cardiovascular diseases. Elevated levels of homocysteine (Hcy) are a marker of cardiovascular risk. Several studies...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Plaque-type Infantile Psoriasis on Both Flank

Kim WO, Yoon SD, Ryoo YW, Kim SA

  • KMID: 2451594
  • Korean J Dermatol.
  • 2019 Jun;57(5):282-284.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Docetaxel-Aggravated Psoriasis

Yang S, Kim BR, Choi CW, Youn SW

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adverse Events after Inappropriate In-Home Ultraviolet Phototherapy: Sunburn and Exacerbation of Psoriasis

Park JS, Moon J, Jo SJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent medical therapy for psoriasis

Youn SW

Psoriasis is a chronic inflammatory disease. Medical therapy is the mainstay of the management of psoriasis, and the main target of psoriasis treatment is immunological dysregulation. Cyclosporine and methotrexate, the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Human Embryonic Stem Cells-Derived Mesenchymal Stem Cells Reduce the Symptom of Psoriasis in Imiquimod-Induced Skin Model

Kim CH, Lim CY, Lee JH, Kim KC, Ahn JY, Lee EJ

BACKGROUND: Mesenchymal stem cells (MSCs) can be used for a wide range of therapeutic applications because of not only their differentiation potential but also their ability to secrete bioactive factors....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Morphological Characteristics of Psoriatic Lesions Affect the Accuracy and Reliability of Severity Assessments: Proposal for New Working Criteria for the Psoriasis Area and Severity Index

Choi CW, Kim BR, Yang S, Youn SW

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Real-World Experience with Etanercept Therapy and the Switching Pattern among Korean Patients with Psoriasis after Withdrawal of Etanercept

Choi CW, Lee JS, Yu DA, Kim BR, Youn SW

BACKGROUND: The efficacy and safety of etanercept in the treatment of psoriasis has been proven, and the drug was approved for the treatment of moderate to severe psoriasis. However, there...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Usefulness of the Psoriatic Arthritis Screening and Evaluation Questionnaire to Monitor Disease Activity in Management of Patients with Psoriasis: Findings from the EPI-PSODE Study

Choe YB, Park CJ, Yu DY, Kim Y, Ju HJ, Youn SW, Lee JH, Kim BS, Seo SJ, Yun SK, Park J, Kim NI, Youn JI, Lee SJ, Lee MG, Kim KJ, Ro YS, Song HJ, Shin BS, Ahn SK, Lee JY, Won YH, Jang MS, Kim KH, Kim MH, Kim TY, Choi JH

BACKGROUND: Psoriasis and psoriatic arthritis (PsA) are included in the group of immune-mediated inflammatory diseases (IMIDs) caused by systemic inflammation; however, indicators for monitoring inflammatory activity in patients with psoriasis,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and Safety of Secukinumab for the Treatment of Moderate to Severe Psoriasis in Korea

Ha DL, Kim WI, Yang MY, Lee WK, Kim T, Park S, Lee HJ, Kim GW, Kim HS, Ko HC, Kim MB, Kim BS

  • KMID: 2433637
  • Korean J Dermatol.
  • 2019 Jan;57(1):9-14.
BACKGROUND: Secukinumab, a fully human monoclonal antibody that targets interleukin (IL)-17A, which is a central cytokine in the pathogenesis of psoriasis, has emerged as a promising treatment for moderate to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr